Robert Coopman Consultants Archives - CDR

Where would we be with no generics?

February 26, 2016 by Robert Coopman and Chain Drug Review generic drug industry, generic medications, health care spending in the U.S., medication spending in the U.S., Robert Coopman, Robert Coopman Consultants Opinion

The numbers are in for medication spending in the U.S. for the year 2015. And the story headline could read: Thank You, Generic Medication Industry. Another headline for the same story could read: Alarming U.S. Medication Cost Increase of 12% for 2015. Both headlines would be defensibly accurate. The details are in the continuing bifurcation

Small chains show they can compete

July 10, 2015 by Robert Coopman and Chain Drug Review compounding services, pain management, PCCA, Professional Compounding Centers of America, Robert Coopman, Robert Coopman Consultants, small drug chains Leading Headlines, Opinion, Pharmacy

Large chains — Walgreens, CVS/Pharmacy, Rite Aid and Walmart among them — receive a great deal of attention. Similarly, regional chains including Wegmans, H-E-B, Publix and Schnucks are examples of a force in their respective markets. In smaller geographical and local markets, small drug chains, competing with the aforementioned “big boys,” continue to thrive. There